Who owns Momenta Pharmaceuticals?

Key details on Momenta Pharmaceuticals (Ticker: MNTA)

Who owns Momenta Pharmaceuticals?

Is MNTA a good stock to own? Find out who bought Momenta Pharmaceuticals, who sold Momenta Pharmaceuticals (MNTA) stock, and who holds a large position in Momenta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 10.35M $153.52M Dec. 31, 2015
Visium Asset Management 5.40M $88.58M Sept. 30, 2015
Vanguard 4.84M $72.12M Dec. 31, 2015
BlackRock Fund Advisors 4.67M $69.34M Dec. 31, 2015
Discovery Capital Management 4.50M $66.81M Dec. 31, 2015
T. Rowe Price Associates 4.42M $67.15M March 31, 2015
Scopia Management 3.80M $44.80M Dec. 31, 2012
Inves 3.76M $55.83M Dec. 31, 2015
S.A.C. Capital Advisors 3.03M $35.29M March 31, 2014
Wellington Management Company 2.81M $40.93M Sept. 30, 2012
PRIMECAP Management Company 2.74M $40.65M Dec. 31, 2015
North Tide Capital 2.50M $30.10M Dec. 31, 2014
Deerfield Management Company 2.01M $28.89M Sept. 30, 2013
STATE STREET CORPORATION 1.97M $29.27M Dec. 31, 2015
Apex Capital Management 1.94M $17.90M March 31, 2016
Palo Alto Investors 1.89M $22.31M Dec. 31, 2012
BlackRock Institutional Trust Company, N.A. 1.77M $26.25M Dec. 31, 2015
Tocqueville Asset Management 1.61M $26.50M Sept. 30, 2015
Sectoral Asset Management 1.58M $24.08M March 31, 2015
D. E. Shaw & Co 1.58M $23.42M Dec. 31, 2015

Who sold Momenta Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
OppenheimerFunds June 30, 2011 5.50M $107.07M
Citi March 31, 2011 1.66M $26.30M
OrbiMed Advisors Dec. 31, 2010 2.16M $32.35M
Barclays Dec. 31, 2010 1.70M $25.42M